Search results
Guardant Health Stock Jumps. Blood Test for Cancer Moves Toward FDA Approval.
Barrons.com· 4 hours agoShares of Guardant Health were rising sharply after the cancer company said a Food and Drug...
Blood test to detect colon cancer could move a step closer to FDA approval in the US
KABC 7 Los Angeles· 1 day agoAlto, California-based biotechnology company Guardant Health has applied for US Food and Drug...
Colon Cancers Are Rising Among the Young: Know the Warning Signs
US News & World Report· 3 hours agoIt often took a long time to receive a diagnosis of early-onset colon cancer following these symptoms, however. "Time from sign or symptom presentation to early onset colorectal< ...
Regeneron (REGN) Announces Positive Data on Oncology Candidate
Zacks via Yahoo Finance· 4 hours agoRegeneron's (REGN) REGN7075, in combination with its oncology drug Libtayo, generates anti-tumor...
Colon cancers are rising among the young: New study outlines the warning signs
Medical Xpress· 2 hours agoIt often took a long time to receive a diagnosis of early-onset colon cancer following these symptoms, however. "Time from sign or symptom presentation to early onset colorectal< ...
Guardant Health Jumps — As Exact Sciences Slumps — On A Key FDA Move For Blood Tests
Investor's Business Daily· 2 hours agoThat's in line with 50% to 65% for FIT, Mikson said. "Given the test's relatively poor pre-cancer...
Quarterbacking Care for Cancer Survivors
Medscape· 13 hours agoPrimary care clinicians face challenges in knowledge and care coordination as they care for a rising number of cancer survivors in the United States,...
Some People May Safely Extend Colonoscopy Screenings to Every 15 Years, Research Shows
Health.com· 4 days agoIn the U.S., most screening guidelines recommend people get a colonoscopy every 10 years to check...
Blood test to detect colon cancer could move a step closer to FDA approval in the US
CNN.com· 20 hours agoAlto, California-based biotechnology company Guardant Health has applied for US Food and Drug...
ASCO: Combination therapy significantly improves o | Newswise
Newswise· 13 hours agoThe median progression-free survival, which is the amount of time during and after treatment when the cancer does not worsen or progress, with the...